The mathematician versus the malignancy

Nature Medicine

Volumn 20, Issue 5, 2014, Pages 460-463

  Dolgin, Elie ^a  

^a Nature Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; HUMAN; MARKOV CHAIN; MATHEMATICAL MODEL; MAXIMUM TOLERATED DOSE; METASTATIC BREAST CANCER; NEOPLASM; ONCOLOGY; PRIORITY JOURNAL; TUMOR VOLUME; MATHEMATICAL PHENOMENA; NOTE; THEORETICAL MODEL;

ANTINEOPLASTIC AGENTS; HUMANS; MATHEMATICAL CONCEPTS; MODELS, THEORETICAL; NEOPLASMS;

EID: 84902978430     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0514-460     Document Type: Article

References (11)

1. Chmielecki, J. et al. Sci. Transl. Med. 3, 90ra59 (2011).
2. Foo, J., Chmielecki, J., Pao, W. & Michor, F. J. Thorac. Oncol. 7, 1583-1593 (2012).
3. Norton, L. & Simon, R. Cancer Treat. Rep. 61, 1307-1317 (1977).
4. Citron, M.L. et al. J. Clin. Oncol. 21, 1431-1439 (2003).
5. Goldie, J.H. & Coldman, A.J. Cancer Treat. Rep. 63, 1727-1733 (1979).
6. Bonadonna, G., Zambetti, M., Moliterni, A., Gianni, L. & Valagussa, P. J. Clin. Oncol. 22, 1614-1620 (2004).
7. Gatenby, R.A., Silva, A.S., Gillies, R.J. & Frieden, B.R. Cancer Res. 69, 4894-4903 (2009).
8. Silva, A.S. et al. Cancer Res. 72, 6362-6370 (2012).
9. Foo, J., Drummond, M.W., Clarkson, B., Holyoake, T. & Michor, F. PLoS Comput. Biol. 5, e1000503 (2009).
10. Leder, K. et al. Cell 156, 603-616 (2014).
11. Verhaak, R.G. et al. Cancer Cell 17, 98-110 (2010).